Courtagen raises $8M for biomarker work

Massachusetts-based Courtagen has raised $8 million from 67 investors to support development of protein biomarkers for disease detection using technology it bought from Decision Biomarkers in 2009, according to Xconomy. The company was previously known as Avantra Bioscience. Article